StockData
Axogen, Inc. logo

Axogen, Inc. (AXGN) stock

AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30142% above fair value
$55.37−0.01 (-0.02%)

Close on Nov 17, 2026Market cap $3.31BP/E –Yield –

Axogen total assets

Total assets on the balance sheet at the end of each period.

Axogen's total assets was $550.34M at Sep 30, 2026. For fiscal 2025 it was $221.69M, up 8.8% from the year before. Over ten years it grew 19.7% a year on average. The highest annual figure on record is $221.69M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$221.69M+8.8%
FY2024Dec 31, 2024$203.73M+3.5%
FY2023Dec 31, 2023$196.83M+0.7%
FY2022Dec 31, 2022$195.39M-6.1%
FY2021Dec 31, 2021$208.02M+3.3%
FY2020Dec 31, 2020$201.38M+30.2%
FY2019Dec 31, 2019$154.64M-3.5%
FY2018Dec 31, 2018$160.17M+172.1%
FY2017Dec 31, 2017$58.88M+27.0%
FY2016Dec 31, 2016$46.36M+26.3%
FY2015Dec 31, 2015$36.70M+123.8%
FY2014Dec 31, 2014$16.40M-40.8%
FY2013Dec 31, 2013$27.68M+36.8%
FY2012Dec 31, 2012$20.23M+61.9%
FY2011Dec 31, 2011$12.50M+95.1%
FY2010Dec 31, 2010$6.41M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$550.34M+154.3%
Q2 FY2026Jun 30, 2026$304.86M+48.4%
Q1 FY2026Mar 31, 2026$289.49M+47.6%
Q4 FY2025Dec 31, 2025$221.69M+8.8%
Q3 FY2025Sep 30, 2025$216.40M+12.7%
Q2 FY2025Jun 30, 2025$205.45M+8.7%
Q1 FY2025Mar 31, 2025$196.17M+5.2%
Q4 FY2024Dec 31, 2024$203.73M+3.5%
Q3 FY2024Sep 30, 2024$191.99M-1.4%
Q2 FY2024Jun 30, 2024$188.93M-1.4%
Q1 FY2024Mar 31, 2024$186.52M-1.6%
Q4 FY2023Dec 31, 2023$196.83M+0.7%
Q3 FY2023Sep 30, 2023$194.63M-0.5%
Q2 FY2023Jun 30, 2023$191.64M-2.3%
Q1 FY2023Mar 31, 2023$189.47M-4.3%
Q4 FY2022Dec 31, 2022$195.39M-6.1%
Q3 FY2022Sep 30, 2022$195.52M-6.9%
Q2 FY2022Jun 30, 2022$196.08M-6.9%
Q1 FY2022Mar 31, 2022$198.03M+0.3%
Q4 FY2021Dec 31, 2021$208.02M+3.3%
Q3 FY2021Sep 30, 2021$209.97M+8.3%
Q2 FY2021Jun 30, 2021$210.53M+23.9%
Q1 FY2021Mar 31, 2021$197.37M+36.2%
Q4 FY2020Dec 31, 2020$201.38M+30.2%
Q3 FY2020Sep 30, 2020$193.94M+25.8%
Q2 FY2020Jun 30, 2020$169.96M+8.5%
Q1 FY2020Mar 31, 2020$144.88M-9.7%
Q4 FY2019Dec 31, 2019$154.64M-3.5%
Q3 FY2019Sep 30, 2019$154.19M-4.6%
Q2 FY2019Jun 30, 2019$156.60M-2.5%
Q1 FY2019Mar 31, 2019$160.49M+190.9%
Q4 FY2018Dec 31, 2018$160.17M+172.1%
Q3 FY2018Sep 30, 2018$161.66M+282.8%
Q2 FY2018Jun 30, 2018$160.54M+275.4%
Q1 FY2018Mar 31, 2018$55.17M+27.5%
Q4 FY2017Dec 31, 2017$58.88M+27.0%
Q3 FY2017Sep 30, 2017$42.23M–
Q2 FY2017Jun 30, 2017$42.77M–
Q1 FY2017Mar 31, 2017$43.27M–
Q4 FY2016Dec 31, 2016$46.36M–

More Axogen figures

See a number that looks wrong?